ascopubs.org

Repurposing hemostatic drug desmopressin in AVPR2-expressing triple-negative breast cancer: Target expression analysis and preclinical antineoplastic effects on tumor growth ...

Effect of DeltaRex-G ± DeltaRex-G Plus (an FDA-approved drug) on advanced chemoresistant pancreatic cancer, sarcoma, and breast cancer. This is an ASCO Meeting Abstract from the 2024 ASCO Annual ...
News Medical

The association between neighborhood deprivation, DNA methylation, and gene expression in breast tissue for Black and White women with breast cancer

Despite advances in breast cancer treatment reducing mortality across all racial and ethnic groups, Black women face a 40% higher death rate than White women. Socioeconomic disparities, notably in ...
ascopubs.org

Estrogen receptor expression in residual breast cancer following neoadjuvant chemotherapy.

Real-world patterns of Oncotype DX (O-Dx) testing and chemotherapy (CT) use among patients with early-stage, hormone receptor–positive (HR+) breast cancer (BC). Molecular and immune profiling of ...
Medscape

Prevalence and Outcomes of Breast Milk Expressing in Women With Healthy Term Infants

Considering the paucity of discussion in the literature, it appears that the implications of expressing on maternal mental health warrants attention. Identify relationships between breast pump use and ...
FiercePharma

ASCO: AstraZeneca, Daiichi's Enhertu looks to make history again in HER2-ultralow breast cancer

After Enhertu pioneered the HER2-low category in breast cancer treatment, AstraZeneca and Daiichi Sankyo are now hopeful that the antibody-drug conjugate can reach tumors with an even lower expression ...
CURE

Genetic Discovery Explains Drug Resistance in Breast Cancer

Resistant cells demonstrated global decreases in DNA accessibility with localized opening at resistance-driving loci, ...